Key Metrics
2.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
46
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.62
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
CrossRef -
Scopus -
Web of Science
Topics Covered
- Familial hypercholesterolemia
- Cardiovascular risk factors
- Coronary heart disease
- Optical coherence tomography
- Dyslipidemia
- European atherosclerosis society
- Lipoprotein apheresis
- Apolipoprotein B
- Coronary disease
- Apheresis
- Lipid clinic
- Percutaneous coronary intervention
- Lipid management
- Endothelial dysfunction
- Metabolic syndrome
- Alirocumab
- PCSK9 Inhibitors
- Arterial stiffness
- Microbubbles
- Cardiovascular outcomes
Journal Specifications
| Overview | |
| Publisher | ELSEVIER IRELAND LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
Planning to publish in Atherosclerosis Supplements ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Editorial Board
- 1 Sep 24
- Atherosclerosis Plus
-
Full paper
HEART UK 37th Annual Medical & Scientific conference
- 1 Sep 24
- Atherosclerosis Plus
-
Full paper
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes
- 1 Sep 24
- Atherosclerosis Plus
-
Full paper
Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease
- 11 Jul 24
- Atherosclerosis Plus
-
Full paper
Using cardiovascular and imaging biomarkers to identify patients with familial hypercholesterolaemia
- Atherosclerosis Plus
-
Full paper
Total Circulating PCSK9 Positively Correlates with Age and Free Circulating PCSK9 Positively Correlated with Body Mass Index in Healthy Volunteers
- Atherosclerosis Plus
Scite analysis
Powered by scite_
13.6k articles received 16k citations see all
- 648 Supporting
- 14,363 Mentioning
- 101 Contrasting
Editorial notices
- 1 Retractions
- 3 Withdrawals
- 0 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How long has Atherosclerosis Supplements been actively publishing?
Atherosclerosis Supplements has been in operation since 2000 till date.
What is the publishing frequency of Atherosclerosis Supplements ?
Atherosclerosis Supplements published with a Bi-monthly frequency.
How many articles did Atherosclerosis Supplements publish last years ?
In 2023, Atherosclerosis Supplements published articles.
What is the eISSN & pISSN for Atherosclerosis Supplements ?
For Atherosclerosis Supplements,eISSN is 1878-5050 and pISSN is1567-5688.
What is Citescore for Atherosclerosis Supplements ?
Citescore for Atherosclerosis Supplements is 2.1.
What is H index for Atherosclerosis Supplements ?
H index for Atherosclerosis Supplements is 46.
What is SNIP score for Atherosclerosis Supplements ?
SNIP score for Atherosclerosis Supplements is 0.62.
Who is the publisher of Atherosclerosis Supplements ?
ELSEVIER IRELAND LTD is the publisher of Atherosclerosis Supplements.